Brief: APONTIS PHARMA Publishes Start Study In Scientific Journal
20/04/2022 06:32
April 20 (Reuters) - APONTIS PHARMA AG APPHG.DE :
* START STUDY PUBLISHED IN SCIENTIFIC JOURNAL - COST
REDUCTION IN
THE TREATMENT OF CARDIOVASCULAR PATIENTS BY SINGLE PILL THERAPY
* IN TOTAL, DATA FROM 59,336 PATIENTS WERE INCLUDED IN
EVALUATION
Source text for Eikon: ID:nEQ5ysfRPa
Further company coverage: APPHG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Apontis Pharma AG
See all newsBrief: Bruno Wohschlegel To Leave Apontis Pharma As CEO End Of August
Brief: APONTIS PHARMA Q1 EBITDA EUR 1.3 Million
Brief: Apontis Pharma Says Zentiva AG Submits Formal Request To Carry Out A Merger
Brief: Zentiva Says Amendeds Offer To Acquire Each Outstanding Share Of Apontis Pharma In Cash By Waiving Condition Of A Minimum Acceptance
Brief: Apontis Pharma: Zentiva To Launch Voluntary Public Purchase Offer At EUR 10.00 Per Share